CA
NZ
UK
AU
IND
US
MapLight Therapeutics, Inc. announced on July 27, 2026, the topline results from the ZEPHYR Phase 2 trial evaluating ML-007C-MA in inpatient adult participants with schizophrenia experiencing acute exacerbation of psychosis. The company disclosed the results through a conference call and accompanying presentation on the …
Neumora Therapeutics, Inc. (NASDAQ: NMRA) announced favorable pre-clinical toxicology results from NMRA-215, its investigational therapeutic candidate, according to a disclosure filed on July 27, 2026. The announcement signals progress in the company's development pipeline and comes as the biopharmaceutical firm advances its clinical-stage programs. …
Ponce Financial Group, Inc., the parent company of Ponce Bank, disclosed its financial results for the second quarter ended June 30, 2026, on July 27, 2026. The announcement included a press release outlining operational and financial performance metrics alongside a formal investor presentation. The …
Boost Run Inc. (NASDAQ: BRUN) announced on July 27, 2026, that it delivered a notice of redemption for all outstanding warrants on July 21, 2026, with a redemption deadline set for August 20, 2026. The company has already received $58.8 million in gross cash …
Precision BioSciences, Inc. announced significant changes to its executive leadership team effective August 1, 2026. Alex Kelly, who has served as Chief Financial Officer since May 2021, was promoted to Chief Operating Officer with an increased annual base salary of $510,000. Naresh Tanna, who …
Strive, Inc. announced on July 27, 2026, that it has acquired 79 bitcoin during the week of July 20–24, 2026, at an average price of approximately $65,723 per bitcoin inclusive of fees and expenses. The purchase brings the company's total bitcoin holdings to 20,000 …
Strategy Inc (NASDAQ: MSTR) disclosed on July 27, 2026, that it sold 5.4 million shares of Class A common stock generating $544.5 million in net proceeds during the week of July 20-26, 2026. The company simultaneously repurchased 288,930 shares of Variable Rate Series A …
Kyverna Therapeutics, Inc. has entered into a new Clinical and Commercial Supply Agreement with ElevateBio Basecamp, Inc. effective July 23, 2026, replacing a prior development and manufacturing services arrangement. The agreement establishes a structured framework for the production and supply of mivocabtagene autoleucel (miv-cel), …
Cadiz Inc. announced on July 27, 2026, that Stanley E. Speer will retire as Chief Financial Officer effective September 1, 2026, and will transition to an advisory role through December 31, 2026. Jacinto J. Hernandez, a veteran investment professional with extensive board experience at …
Alliance Resource Partners, L.P., the NASDAQ-listed coal and natural resources partnership, announced its quarterly earnings and operating results for the period ended June 30, 2026, on July 27, 2026. The partnership disclosed its second quarter 2026 financial performance through a press release filed with …
Please wait processing your request...